Results 161 to 170 of about 747,735 (358)

Azaserine: Pathological and pharmacological studies [PDF]

, 1957
Stephen S. Sternberg, Frederick S. Philips, Barbara B. Adams, Beatrice N. Greene, Barbara Wheelock   +4 more
openalex   +1 more source

Robust acute myeloid leukemia engraftment in humanized scaffolds using injectable biomaterials and intravenous xenotransplantation

Molecular Oncology, EarlyView.
Patient‐derived xenografts (PDXs) can be improved by implantation of a humanized niche. We tested different biomaterials and approaches, and demonstrate that the combination of an injectable biomaterial for scaffold creation plus an intravenous route for acute myeloid leukemia (AML) xenotransplantation provide the most convenient and robust approach to
Daniel Busa, Zdenka Herudkova, Jan Hyl, Jakub Vlazny, Filip Sokol, Kvetoslava Matulova, Adam Folta, Jakub Hynst, Lucy Vojtova, Leos Kren, Martin Repko, Zdenek Racil, Jiri Mayer, Martin Culen   +13 more
wiley   +1 more source

Angiogeneza u centralnom nervnom sistemu - uloga faktora rasta vaskularnog endotela [PDF]

Vojnosanitetski Pregled, 2005
Lačković Vesna, Kostić Vladimir S., Šternić Nadežda, Kanjuh Vladimir, Vuković Irena   +4 more
doaj   +1 more source

Clinical and Pathological Report of the Rotunda Hospital, Dublin, for the Year 1904–5.* [PDF]

, 1906
E. Hastings Tweedy, Arthur N. Holmes, Robert J. Rowlette   +2 more
openalex   +1 more source

Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer

Molecular Oncology, EarlyView.
This study employed targeted metabolomic profiling to identify 302 distinct metabolites present in platelet‐rich plasma (PRP), revealing aberrant metabolic profiles amongst individuals diagnosed with colorectal cancer (CRC). Compared to carcinoembryonic antigen (CEA) and cancer antigen 19‐9 (CA199), our metabolite panel showed improved sensitivity ...
Zuojian Hu, Fenglin Shen, Yang Liu, Ziqing Zhong, Yongling Chen, Zhiyuan Xia, Cuiju Mo, Hongxiu Yu   +7 more
wiley   +1 more source

The Pathological Changes in Chronic Bronchitis and Emphysema [PDF]

, 1958
Lynne Reid
openalex   +1 more source

KMT2A degradation is observed in decitabine‐responsive acute lymphoblastic leukemia cells

Molecular Oncology, EarlyView.
We demonstrate that decitabine (DEC) not only degrades the DNA methyltransferase DNMT1 but also the leukemic driver lysine methyltransferase KMT2A likely due to structural similarity of the DNA‐binding CXXC domains. DEC influences KMT2A downstream processes and synergizes with menin inhibitor revumenib (REV) to decrease leukemic cell proliferation, and
Luisa Brock, Lina Benzien, Sandra Lange, Maja Huehns, Alexandra Runge, Catrin Roolf, Anett Sekora, Gudrun Knuebel, Hugo Murua Escobar, Christian Junghanss, Anna Richter   +10 more
wiley   +1 more source

Evaluation of Arginase Activity in Normal Epidermal Tissue and Pathological Stratum Corneum11From the Dermatology Service, General Medicine Branch, National Cancer Institute, National Institutes of Health, Public Health Service, U.S. Department of Health, Education, and Welfare, Bethesda, Maryland.

, 1958
Simon Rothberg, Eugene J. Van Scott, S.L. Newberry   +2 more
openalex   +1 more source

A CLINICAL AND PATHOLOGICAL STUDY OF A CONDITION OCCURRING IN THE AGED USUALLY ATTRIBUTED TO CEREBRAL ARTERIOSCLEROSIS [PDF]

, 1916
Charles Metcalfe Byrnes
openalex   +1 more source